Beta-fibrinogen (-455 G/A) and Integrin beta-3 (PLA1/A2) polymorphisms and recurrent pregnancy loss in Gaza strip-Palestine

Authors

  • Manal G. Al-Astal Department of Medical Laboratory Sciences, Islamic University of Gaza, Gaza, Palestine
  • Fadel A. Sharif Department of Medical Laboratory Sciences, Islamic University of Gaza, Gaza, Palestine

Keywords:

β–fibrinogen, Integrin beta-3, gene polymorphism, RPL, Gaza Strip, Palestine

Abstract

Background: This study was conducted in order to determine the relationship between the common polymorphisms in β-fibrinogen -455 G/A (rs1800790) and Integrin beta-3 T196C (PLA1/A2, rs5918) and recurrent pregnancy loss (RPL) in a group of Palestinian women residing in Gaza strip.

Methods: The study presented here is a retrospective association study with a case-control design. The study population consisted of 102 women who suffered from RPL and 97 healthy women matched for age and without a previous history of RPL. DNA extracted from blood samples of all subjects was investigated for the β-fibrinogen (-455 G>A) and Integrin beta-3 (PLA1/A2) polymorphisms using PCR-RFLP and PCR-SSP, respectively.

Results: The study revealed that β–fibrinogen -455G/A minor allele frequency (allele A) and its homozygous genotype (AA) were not significantly different between the RPL and the control groups. Likewise, there was no significant difference in the distribution of the ITGB-3 variant allele (PLA2) or PLA2/A2 genotype between the two groups. β–fibrinogen AA genotype was evident in 3.9% of the patients and in 4.1% of the controls (P-value = 0.94). The frequency of PLA2/A2 was observed in 2.0% of the patients and in 2.1% of the controls (P-value = 0.96).

Conclusion: Results of the present study indicate that there is no significant association between the β–fibrinogen
(455 G>A) or Integrin beta-3 (PLA1/A2) common polymorphisms and the occurrence of RPL in Gaza strip. This non-significant relation indicates that the investigated polymorphisms do not constitute a tangible risk for RPL in our population. Therefore, it is not recommended to consider these two polymorphisms when screening for inherited thrombophilia in Gaza strip.

References

Abu-Asab NS, Ayesh SK, Ateeq RO, Nassar SM, EL-Sharif WA. Association of Inherited Thrombophilia with Recurrent Pregnancy Loss in Palestinian Women. Obstetrics and Gynecology International 2011; Article ID 689684, 6 pages doi:10.1155/2011/689684.

Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J. Thrombosis and Haemostasis 2005; 3(2):227-229.

Brenner B. Thrombophilia and adverse pregnancy outcome. Obstet Gynecol Clin North Am 2006;33:443–456.

Cernecab F, Ricci G, Simeoneb R, Malisanoa M, Albericoa S, Guaschinoa S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol. 1997; 73(1):31-33.

Chiras T, Papadakis ED, Katopodi A, Chatzianesti E, Fourtounas K, Papakonstantinou S, Theodoropoulos I, Dakouras A, Zerefos N, Valis D, Exarchou HT. Platelet GP IIIA Polymorphism HPA-1 (PLA1/2) Is Associated with Hypertension as the Primary Cause for End-stage Renal Disease in Hemodialysis Patients from Greece. In Vivo. 2009; 23:177–182.

Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006; 55:360–368.

Ford HB, Schust DJ. Recurrent Pregnancy Loss. Etiology, Diagnosis, and Therapy. Reviews in Obstetrics and Gynecology 2009; 2:76-83.

Goncharovaa I, Babushkinaa O, Minaychevaa L, Markovaa V, Kulisha E, Salakhovb R, Makeevaa O, Puzyreva V. Prevalence of Alleles of Polymorphic Variants Leu33Pro and Leu66Arg Gene ITGB3 among Inhabitants of Siberia. Russian Journal of Genetics. 2013;49:877-880.

Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roumen R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol.2006;56:230–236.

Ivanov PD, Komsa-Penkove RS, Konova EI, Tsvyatkovska TM, Kovacheva, Simeonova MN, Tanchev SY. Polymorphism A1/A2 in the cell surface integrin subunit β3 and disturbance of implantation and placentation in women with recurrent pregnancy loss. Fetil Steril 2010; 94(7):2843-2845.

Jeddi-Tehrani M, Torabi R, Zarnani AH, Mohammadzadeh A, Arefi S, Zeraati H, Akhondi MM, Chamani-Tabris L, Idali F, Emami S, Zarei S. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. Am J Reprod Immunol 2011; 66(2):149-156.

Lambrinoudaki I, Armeni E, Kaparos GJ, Christodoulakos GE, Sergentanis TN, Alexandrou A, Creatsa M, Kouskouni E. The frequency of early, spontaneous miscarriage associated with the leu33pro polymorphism of Glycoprotein IIIa: A pilot study. Australian and New Zealand Journal of Obstetrics and Gynaecology 2010; 50(5):485-490.

Lavigne GL, Nouvellon EC, Mercier E, Quere I, Dauzat M, Mares P, Gris JC. The association between hereditary thrombophilias and pregnancy loss. Haematologica. 2005;90:1223-1230.

Leander R, Wiman B, Hallqvist J, Falk G, De Faire U. The G-455A polymorphism of the fibrinogen Bb-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. Journal of Internal Medicine.2002; 252: 332-341.

Ozdemir O, Yenicesu G I, Silan F, Köksal B, Atik S, Ozen F, Göl M, Cetin A. Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations. Genet Test Mol Biomarkers.2012;16:279-286.

Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol. 2001;46:124-131.

Ruzzi L, Ciarafoni I, Silvestri L, Semeraro ML, Abeni D. Association of PLA2 polymorphism of the ITGB3 gene with early fetal loss. Fertil Steril 2000; 83(2):511-512.

Tan J, Lian LH, Nadarajan VS: Genetic polymorphisms of human platelet antigens-1 to -6, and -15 in the Malaysian population. Blood Transfus. 2012;10:368–376.

Ticconi C, Mancinelli F, Gravina P, Federici G, Piccione E, Bernardini S. Beta-fibrinogen G-455A polymorphisms and recurrent miscarriage. Gyecol Obstet Invest 2011;71(3):198-201.

Torabi R, Zarei S, Zeraati H, Zarnani A, Akhondi M, Hadavi R, Shiraz E, Jeddi-Tehrani M. Combination of Thrombophilic Gene Polymorphisms as a Cause of Increased the Risk of Recurrent Pregnancy Loss. J Reprod Infertil. 2012;13:89-94.

Xiang-feng L, Hong-jiang Y, Xiao-yang Z, Lai-yuan W, Jian-feng H, Dong-feng G. Influence of fibrinogen β-chain gene variations on risk of myocardial infarction in a Chinese Han population. Chinese Medical Journal 2008; 121(16):1549-1553.

Yenicesu G I, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, Yildiz C, Nadir K. A Prospective Case-Control Study Analyzes 12 Thrombophilic Gene Mutations in Turkish Couples with Recurrent Pregnancy Loss. Am J Reprod Immunol. 2010; 63:126-136.

Downloads

Published

2016-12-24

Issue

Section

Original Research Articles